Related Experiment Video
Updated: Apr 6, 2026
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1
Huifen Li1, Weihua Huang2, Rongcheng Luo3
1Department of Chemotherapy, Zhongshan People's Hospital, Zhongshan, Guangdong, 528400, China.
Background:
MicroRNAs (miRNAs) can serve as tumor suppressors and might provide an efficient strategy for annihilating tumor cells. Nevertheless, the potential role of miR-325 in hepatocellular carcinoma (HCC) is still unknown.
Methods:
Using RT-PCR, immunoblots invasion assays and bioinformatics strategies, we investigated the potential role of miR-325 in HCC.
Results:
We showed that miR-325 was decreased and HMGB1 was increased in 99 patients with hepatocellular carcinoma. MiR-325 inhibition promoted cell invasion and proliferation, while miR-325 upregulation inhibited cell invasion and proliferation by using transwell and CCK8 assays. We further showed that HMGB1 might be a direct target of miR-325 and is negatively regulated by miR-325. Down-regulation of miR-325 predicts poor prognosis for HCC patients.
Conclusions:
These findings implied that miR-325 regulates cell invasion and proliferation via targeting HMGB1 and may be a potential prognostic marker for HCC.
Virtual Slides:
The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/4655707031717989.
Insights
MicroRNA-325 (miR-325) acts as a tumor suppressor in hepatocellular carcinoma (HCC) by inhibiting cell invasion and proliferation. Its down-regulation is linked to poor prognosis in HCC patients, suggesting it is a potential prognostic marker.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- MicroRNAs (miRNAs) are implicated in tumor suppression and cancer treatment.
- The specific role of miR-325 in hepatocellular carcinoma (HCC) remains uncharacterized.
Purpose of the Study:
- To investigate the function and mechanism of miR-325 in hepatocellular carcinoma (HCC).
- To determine if miR-325 can serve as a prognostic biomarker for HCC.
Main Methods:
- Reverse transcription-quantitative polymerase chain reaction (RT-PCR) to quantify miR-325 and HMGB1 expression.
- Immunoblotting, invasion assays (Transwell), and cell counting kit 8 (CCK8) assays to assess cell behavior.
- Bioinformatic strategies to predict and validate miR-325 targets.
Main Results:
- miR-325 expression was significantly decreased, while HMGB1 expression was increased in HCC tissues compared to normal tissues.
- miR-325 inhibition enhanced HCC cell invasion and proliferation.
- miR-325 upregulation suppressed HCC cell invasion and proliferation.
- HMGB1 was identified as a direct target of miR-325, with miR-325 negatively regulating HMGB1 expression.
- Down-regulation of miR-325 correlated with a poor prognosis in HCC patients.
Conclusions:
- miR-325 plays a crucial role in regulating HCC cell invasion and proliferation by targeting HMGB1.
- miR-325 demonstrates potential as a prognostic biomarker for hepatocellular carcinoma.
More Related Videos
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs
01:22MicroRNAs